Latest News about VERV
Recent news which mentions VERV
From MarketWatch
From Benzinga
Why Did BMO Capital Markets Raise Price Target For Gene Stock One Month After Initiating Coverage
July 18, 2022
From Benzinga
From Benzinga
From Benzinga
A few trade ideas for the last week of June 2022
June 25, 2022
From AC Investor Blog
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
April 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
From Benzinga
68 Biggest Movers From Yesterday
March 16, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
March 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 19, 2022
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Barron's Latest Picks And Pans: Alleghany, Blade Air Mobility, Gene Therapy Picks And More
November 06, 2021
From Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
From Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 30, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
From Benzinga
Verve Therapeutics' Gene-Editing Therapy Shows Encouraging Preclinical Action In Cardiovascular Disease
September 23, 2021
Tickers
VERV
From Benzinga
48 Biggest Movers From Friday
September 20, 2021
From Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
August 31, 2021
From Motley Fool
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.